101 results about "Narcotic" patented technology

A multi-zonal system and method for detecting contraband substances associated with a human subject. Objects containing such substances may be carried by the subject or in a garment worn by the subject, or as vapors entrained by the subject's garments. Alternatively, the substance may be present as small particles or residues present on skin, garment fibers, or the like that may be dislodged from the subject or his immediate effects. The system comprises: (i) an examination station through which the subject passes; (ii) sample generation means to produce a sample for analysis, comprising a plurality of air jets disposed in the examination station to impinge flowing gas onto pre-selected zones on the subject; (iii) collection means operative to acquire and convey the sample, comprising a plurality of collection ports disposed in the examination station to receive gas deflected by the subject from the air jets; (iv) analysis means in communication with the collection means to receive the sample and carry out a chemical analysis to detect the contraband substances; and (v) signal means operably connected to the analysis means for indicating detection of the contraband substances. Preferably the system employs a chemiluminescent detector based on the reaction of luminol with NO₂ produced by pyrolysis of explosive or other contraband substance and is capable of high throughput, accurate screening in real time of a large number of subjects, e.g. persons being screened in an airport.

The present disclosure involves a system for monitoring patients, and more specifically post-operative patients receiving narcotics, and a novel apparatus for automatically delivering a narcotic-reversing agent, including but not limited to the agent commonly known as naloxone, in response to dangerous respiratory conditions such as respiratory depression or other undesired consequences caused by reaction to narcotic dosage.

An apparatus is provided for detecting whether a person has handled explosives, narcotics or other substances of interest. The apparatus includes a metallic sample collection surface on which a person may place a finger. Upon removal of the finger, the metallic sample collection surface is moved to a desorber. The desorber heats the metallic surface sufficiently to vaporize residue transferred from the person. The vaporized residue then is transmitted to a detector for analysis. The detector also may include a fingerprint reading apparatus for reading the fingerprint of the person and comparing the fingerprint to known fingerprint data.

The invention discloses a Chinese medicinal narcotic. The Chinese medicinal narcotic comprises the following Chinese medicinal components in part by weight: 8 to 10 parts of hindu datura flower, 8 to 10 parts of mint, 2 to 3 parts of toad venom, 2 to 3 parts of pepper, 2 to 3 parts of borneol, 8 to 10 parts of manchurian wildginger, 8 to 10 parts of unprocessed kusnezoff monkshood root, 8 to 10 parts of szechuan lovage rhizome, 8 to 10 parts of angelica sinensis, 8 to 10 parts of fried arisaema root, 8 to 10 parts of heartleaf houttuynia herb and 8 to 10 parts of poppy shell. The components of the narcotic are common pure traditional Chinese medicines, and the narcotic has rational compatibility, small toxic or side effect, anti-shock effect and high safety.

The invention discloses a method for monitoring traced propofol narcotic rapidly and sensitively. In the method, an ion mobility spectrometry technology is taken as a basic detection technology, and an anion mode is adopted to establish a method for monitoring traced propofol narcotic. The method comprises the following steps: feeding a gas sample containing propofol into an ion mobility spectrometry tester for analysis to obtain a detecting signal, and then carrying out qualitation and quantitation. According to the invention, the measurement of a narcotic sample can be detected in real time, and the limit of detection of the propofol narcotic can reach 0.5ppb. The detecting method is simple, convenient, rapid and efficient and is good in reliability.

The invention discloses an anesthetic device with good anesthesia efficacy, wherein the anesthetic device comprises a box body; a motor box is fixedly connected at the bottom of an inner cavity of thebox body, a motor is fixedly connected at the right side of an inner cavity of the motor box, and a first gear is fixedly connected at the output end of the motor; a mixing box is arranged in the inner cavity of the box body and located at the top of the motor box; the bottom of the inner cavity of the motor box is movably connected with a stirring rod through a bearing, and the top of the stirring rod runs through the motor box and the mixing box and extends to the inner cavity of the mixing box. By arrangement of the motor, the first gear, the mixing box, the stirring rod, a second gear, stirring blades, a sealing sleeve and a T-branch tube, the effects of stirring mixing of anesthetics and prevention of uneven mixing of normal saline and anesthetics are achieved, so the problems that aconventional anesthesia device cannot adjust the concentration of anesthetics according to different needs of patients, is not ideal in effect of anesthesia, and brings inconvenience for patients andmedical staff.

The present invention relates to methods of alleviating pain with the administration of norketamine with a narcotic. More particularly, the invention provides a method of alleviating pain through the administration of a dose of norketamine, which, if administered alone would provide sub-optimal analgesic relief, yet provides analgesic relief when combined with a narcotic. In some embodiments, the combination of norketamine with a narcotic, further allows for the administration of a dose narcotic, which would be sub-optimal if used alone, but provides adequate pain relief in combination with norketamine. The invention relates to self-management of pain on an outpatient basis comprising administering via conventional routes, including transdermal, nasal, rectal, oral, transmucosal, intravenous, intramuscular, and other routes, one or more doses of norketamine/opioid compositions effective to alleviate pain to a subject suffering from pain. Uses of norketamine/opioid compositions would also apply, to treating headaches, drug abuse, mood and anxiety disorders, as well as other, neuropsychiatric disorders, both motoric and cognitive, such as Alzheimer's disease, Parkinson's syndrome, which are thought to be caused by neurodegeneration.

The present disclosure involves a system for monitoring patients, and more specifically post-operative patients receiving narcotics/sedatives/opioids, and a novel apparatus for automatically delivering one or more substances such as a reversing agent, including but not limited to the agent commonly known as naloxone, in response to dangerous respiratory conditions such as respiratory depression or other undesired consequences caused by reaction to another dosage being delivered to the subject.

A system and a method for medication identification and inventory control is disclosed. The disclosed system and method were designed to track specified medications' (e.g., narcotics and controlled substances) inventory from manufacturer's lot number all the way to the use/waste stage of the medications and to provide periodic reports and notifications on the medications' usage, breakage, waste and expiration. Further, the disclosed system and method utilizes tamper evident bags with unique identifier to protect and keep accurate track of the medications.

The invention relates to a water-soluble amino acid ester derivative of propofol and application thereof. Amino acid ester of the propofol has a structure with a formula (I), wherein R is shown in the description. The invention also relates a preparation method for a compound with the formula (I), a medicinal salt thereof, a compound-containing medicinal composition and application of the compound serving as narcotic medicines.

The invention relates to a system for delivering anesthesia drugs to a patient. The system comprises means for feeding anesthesia drugs to the patient treated, a measuring device for measuring at least one parameter relating to the effects of the anesthetic drugs fed to the patient, a patient monitor to show the results measured by the measuring devices, and feeding means for feeding patient demographics to the system. The system further comprises means for visual planning of the anesthesia drug delivery before the drugs are actually fed. The system can also comprise means for anesthesia management for drug interaction during the treatment.